Medizinische Klinik und Poliklinik IV Munich, GERMANY
Disclosure(s):
Martin Reincke, MD: Crinetics: Consultant (), Grant Recipient (), Speakers' Bureau (); Else Kröner-Fresenius-Stiftung: Grant Recipient (); European Research Council: Grant Recipient (); German Research Organisation: Grant Recipient (); HRA Pharma: Consultant (), Grant Recipient (), Speakers' Bureau (); Ipsen: Consultant (), Grant Recipient (), Speakers' Bureau (); Lundbeck: Consultant (), Grant Recipient (), Speakers' Bureau (); Novartis: Consultant (), Grant Recipient (), Speakers' Bureau (); Pentixafarm: Consultant (), Grant Recipient (), Speakers' Bureau (); Pfizer: Consultant (), Grant Recipient (), Speakers' Bureau (); Recordati Rare Diseases: Consultant (), Grant Recipient (), Speakers' Bureau ()
